Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. (India) holds 44 active US FDA Type II Drug Master Files and 7 inactive, has DMF or CEP filings on record for 40 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 4 FDA-registered manufacturing sites. 34 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Intas Pharmaceuticals Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/intas-pharmaceuticals-ltd
Overview
Intas Pharmaceuticals Ltd. is a leading Indian pharmaceutical company known for its extensive range of products spanning various therapeutic areas. The company is dedicated to providing affordable healthcare solutions with a strong focus on research and development.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which Intas Pharmaceuticals Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Intas Pharmaceuticals Ltd. holds 44 active (51 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- LEVOTHYROXINE SODIUM USPActive2026-09-23
- SODIUM OXYBATEActive2026-09-18
- MYCOPHENOLATE SODIUM USPActive2026-09-18
- 5-FLUOROURACIL USPActive2026-04-09
- PALBOCICLIBActive2026-02-20
- MYCOPHENOLATE MOFETIL USPActive2026-02-03
- OLAPARIBActive2025-09-12
- RUXOLITINIB PHOSPHATEActive2024-07-24
- BENDAMUSTINE HYDROCHLORIDEActive2023-08-31
- TOFACITINIB CITRATEActive2022-06-22
- SODIUM THIOSULFATEActive2022-02-15
- GEMCITABINE HYDROCHLORIDE USP (PROCESS-III)Active2021-12-24
- PREGABALIN USP (PROCESS-II)Active2021-11-22
- RIBOCICLIB SUCCINATEActive2021-09-30
- PACLITAXEL (SEMI SYNTHETIC) USP (PROCESS-II)Active2021-09-02
- DASATINIBActive2020-12-02
- CARFILZOMIBActive2020-09-08
- DIROXIMEL FUMARATEActive2020-03-27
- DOXORUBICIN HYDROCHLORIDE USPActive2020-01-27
- CARMUSTINE USPActive2019-03-26
- TRIFLURIDINE USPActive2019-03-08
- CAPECITABINE USP (PROCESS III)Active2019-03-04
- TIPIRACIL HYDROCHLORIDEActive2019-02-19
- DOFETILIDE USPActive2018-11-26
- DIMETHYL FUMARATEActive2016-12-09
- PERAMPANELActive2016-06-24
- RIVAROXABAN FORM- I (MICRONIZED)Active2016-06-08
- TERIFLUNOMIDEActive2016-04-21
- DOCETAXEL ANHYDROUS USP (PROCESS II)Active2014-10-29
- VILAZODONE HYDROCHLORIDE (AMORPHOUS)Active2014-10-10
- LURASIDONE HYDROCHLORIDEActive2014-07-09
- FINGOLIMOD HYDROCHLORIDE (FORM 1)Active2014-06-24
- CABAZITAXEL (AMORPHOUS)Active2014-02-20
- PREGABALINActive2014-01-06
- DALFAMPRIDINEActive2013-12-30
- AZACITIDINEActive2013-12-30
- TRAZODONE HYDROCHLORIDE USP (PROCESS-II)Active2013-12-30
- PRASUGREL HYDROCHLORIDEActive2013-06-27
- PACLITAXEL USP (SEMI-SYNTHETIC)Active2013-01-17
- LACOSAMIDEActive2012-10-19
- FESOTERODINE FUMARATEActive2012-10-13
- DECITABINEActive2011-09-21
- CAPECITABINE USPActive2010-11-09
- GEMCITABINE HYDROCHLORIDE USPActive2009-04-15
- RELUGOLIXInactive2024-07-24
- PAZOPANIB HYDROCHLORIDEInactive2020-03-23
- IMATINIB MESYLATE (ß-FORM)Inactive2017-11-27
- APREMILAST (AMORPHOUS)Inactive2017-10-23
- ERLOTINIB HYDROCHLORIDEInactive2016-08-29
- DABIGATRAN ETEXILATE MESYLATE FORM-IInactive2014-07-25
Showing the 50 most relevant of 51 Drug Master Files (active first). The full list is in the FDA DMF list.
Excipient Drug Master Files
Intas Pharmaceuticals Ltd. holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- SODIUM CHOLESTERYL SULFATE FOR PHARMACEUTICAL USEActive2024-03-07
Registered manufacturing sites (4)
Physical sites registered with the US FDA and resolved to Intas Pharmaceuticals Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
34 FDA enforcement records linked to this company.
- warning_letter2026-03-30
FDA Warning Letter (drug product)
- warning_letter2023-11-21
FDA Warning Letter (drug product)
- warning_letter2023-07-28
FDA Warning Letter (drug product)
- 4832022-12-02
Procedures not in writing, fully followed
- 4832022-12-02
Test methods
- 4832022-12-02
Following/documenting laboratory controls
- 4832022-12-02
Complete test data included in records
- 4832022-12-02
Investigations of discrepancies, failures
- 4832022-12-02
Procedures for sterile drug products
- 4832022-12-02
Results not used for expiration dates, storage cond.
- 4832022-12-02
Extent of discrepancy, failure investigations
- 4832022-12-02
Absence of Written Procedures
- 4832022-12-02
Environmental Monitoring System
- 4832022-12-02
Computer control of master formula records
- 4832019-08-02
Scientifically sound laboratory controls
- 4832019-08-02
Air Supply
- 4832019-08-02
Air recirculation of dust from production areas
- 4832019-08-02
Procedure Deviations Recorded and Justified
- 4832019-08-02
Equipment for Environmental Control
- 4832019-08-02
Procedures for sterile drug products
- 4832019-08-02
Procedures not in writing, fully followed
- 4832019-08-02
Environmental Monitoring System
- 4832019-08-02
Absence of Written Procedures
- 4832019-08-02
Equipment Design, Size and Location
- 4832019-08-02
Establishment of calibration procedures
- 4832019-08-02
Validation lacking for sterile drug products
- 4832019-08-02
Suitability of testing methods verified
- 4832019-08-02
Written procedures fail to include
- 4832018-06-08
Investigations of discrepancies, failures
- 4832018-06-08
Environmental Monitoring System
- 4832016-10-19
Calibration/Inspection/Checking not done
- 4832016-10-19
Validation lacking for sterile drug products
- 4832016-10-19
Scientifically sound laboratory controls
- 4832016-10-19
Training , Education , Experience overall
Is this Intas Pharmaceuticals Ltd.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.